Alexandra Koumas

机构：Bexley Hall, Summit Medical Group (United States), Alliance for Safe Kids · ORCID：0000-0003-3680-306X

发表论文 10 篇 · 总被引 14 次 · h-index 2

代表论文

• Estimated impact of guidelines-based initiation of dual antihypertensive therapy on long-term cardiovascular outcomes in 1.1 million individuals (2024 · European Heart Journal - Cardiovascular Pharmacotherapy · 被引 8)
• PCSK9 inhibitor treatment and outcomes in patients with atherosclerotic cardiovascular disease but without prior ischaemic events: an observational study (2026 · European Heart Journal · 被引 3)
• Efficacy and safety of belumosudil as compared with best available therapy for the treatment of cGVHD in the United States (2025 · Blood Advances · 被引 1)
• Simulation model to estimate pretreatment (baseline) low-density lipoprotein cholesterol levels in people living with homozygous familial hypercholesterolemia (2025 · Journal of clinical lipidology · 被引 1)
• Lower rate of ischemic events with PCSK9 inhibition in patients with atherosclerotic cardiovascular disease but without prior ischemic events (2024 · European Heart Journal · 被引 1)
• Transportability to the European Population of Efficacy of Belumosudil as Compared With Physician’s Choice of Best Available Therapy for the Treatment of Chronic Graft Versus Host Disease (2026 · University of Regensburg Publication Server (University of Regensburg))